Cargando…
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays
BACKGROUND: HIV-1 genotyping for antiretroviral drug resistance mutations (DRMs) were developed based basically on subtype B HIV-1 Group M, which represents only 10% of HIV strains worldwide. In sub-Saharan Africa, non-B subtypes HIV-1 largely predominate and HIV-1 genetic diversity could affect the...
Autores principales: | Jenabian, Mohammad-Ali, Talla, Frédéric, Talla, Perrine, Mbopi-Kéou, François-Xavier, Charpentier, Charlotte, Kane, Coumba Toure, Bélec, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743293/ https://www.ncbi.nlm.nih.gov/pubmed/26903701 http://dx.doi.org/10.4103/0300-1652.171613 |
Ejemplares similares
-
LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa
por: Mouafo, Linda Chapdeleine Mekue, et al.
Publicado: (2015) -
Differential influence of race and environment on indeterminate reactivities to non-treponemal and treponemal antigens by immuno-chromatographic dual syphilis rapid test
por: Mbopi-Keou, Francois-Xavier, et al.
Publicado: (2019) -
HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon
por: Mihimit, Abdoulaye, et al.
Publicado: (2020) -
COVID-19: the urgency of the doable for an African scientific leadership
por: Mbopi-Keou, Francois-Xavier, et al.
Publicado: (2020) -
Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry
por: Koyalta, Donato, et al.
Publicado: (2013)